My research group works on pelvic cancers including bladder and prostate, in addition to pathophysiology of the urinary bladder. We combine cell physiology and molecular biology approaches to understand how ion channel and GPCR signalling is involved in cancer progression.  We work closely with radiation biologists and clinical oncologists to better understand the mechanisms underlying damage to the bladder that occurs as a result of radiation therapy.

We recently opened a new research programme in glioblastoma and radiotherapy resistance, which harnesses our expertise in ion channel physiology and cell signalling with radiation biology.